Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU

Condition(s) studied

Investigational drug(s) / intervention(s)

Written informed consent with infographic: Potential participants are provided a visual infographic depicting the key elements of the written consent form in addition to the standard written consent form.

Compensation: Potential participants are provided an e-gift card to Amazon or Second Cup as a reward for completing the enrollment questionnaire.

Study summary

There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).

Eligibility

Primary outcome measure(s)

• Recruitment percentage — At enrolment
  Family member participants enrolled/ family member participants approached
• Retention percentage — From enrolment until 6 month follow-up completion
  Family member participant completing follow-up/family member participants enrolled

Trial sites (1)

More Lady Davis Institute trials in Canada

Other trials for the same condition